Regulation of the angiotensin AT1 receptor by hypercholesterolaemia

Diabetes, Obesity and Metabolism

Volumn 2, Issue 4, 2000, Pages 223-228

  Nickenig, G ^a   Wassmann, S ^a   Bohm M ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; CHOLESTEROL; CYTOKINE; G PROTEIN COUPLED RECEPTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN; NEUROHORMONE; NITRIC OXIDE; STATIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ATHEROSCLEROSIS; BLOOD PRESSURE REGULATION; CELL PROLIFERATION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CYTOKINE RELEASE; HEART MUSCLE CELL; HOMEOSTASIS AND REGULATION; HORMONAL REGULATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; LIPOPROTEIN BLOOD LEVEL; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; RABBIT; RECEPTOR UPREGULATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RESTENOSIS; REVIEW; RISK FACTOR; VASOCONSTRICTION;

EID: 0034525602     PISSN: 14628902     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1463-1326.2000.00060.x     Document Type: Review

References (34)

1. Renin-angiotensin system: Biochemistry and mechanism of action
2. Molecular biology of the renin-angiotensin system
3. Angiotensin II receptors and angiotensin II receptor antagonists
4. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
5. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4s)
6. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels: The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study
7. A population at risk: Prevalence of high cholesterol levels in hypertensive patients in the Framingham study
8. Atherosclerosis and the arterial smooth muscle cell
9. The pathogenesis of atherosclerosis: A perspective for the 1990s
10. The 'best' of cholesterols, the 'worst' of cholesterols: A tale of two receptors
11. Lipoprotein metabolism
12. Lipoprotein trafficking in vascular cells. Molecular trojan horses and cellular saboteurs
13. Generation of intracellular signals by low density lipoprotein is independent of the classical LDL receptor
14. Novel activities for low density lipoprotein in vascular smooth muscle cells
15. Oxidized low-density lipoprotein decreases the expression of endothelial nitric oxide synthase
16. Lipoproteins increase growth of mitogen-stimulated arterial smooth muscle cells
17. Lipoproteins and angiotensin II exert synergistic effects on signalling processes in vascular smooth muscle cells
18. Trandolapril inhibits atherosclerosis in the Watanabe heritable hyperlipidemic rabbit
19. Down-regulation by growth factors of vascular smooth muscle angiotensin receptor gene expression
20. Angiotensin II down regulates the vascular smooth muscle AT1 receptor by transcriptional and posttranscriptional mechanisms: Evidence for homologous and heterologous regulation
21. Enhanced AT1 receptor mRNA degradation and induction of polyribosomal mRNA binding proteins by angiotensin II in vascular smooth muscle cells
22. Oestrogen modulates AT1 receptor gene expression in vitro and in vivo
23. Insulin induces up-regulation of vascular AT1 receptor gene expression by posttranscriptional mechanisms
24. Regulation of vascular angiotensin II receptors during altered sodium intake
25. Up-regulation of vascular angiotensin II receptor gene expression by low density lipoprotein in vascular smooth muscle cells
26. Hypercholesterolaemia is associated with enhanced angiotensin AT1 receptor expression
27. Atorvastatin down-regulates AT1 receptor gene expression and cell proliferation in vascular smooth muscle cells
28. Incidence of coronary heart disease and lipoprotein cholesterol levels: The Framingham study
29. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells
30. Nitric oxide, free radicals and cell signalling in cardiovascular disease
31. Hypercholesterolaemia increases endothelial superoxide anion production
32. Angiotensin converting enzyme inhibition with quinapril improves endothelial dysfunction in patients with coronary artery disease
33. Effects of quinapril on coronary blood flow in coronary artery disease patients with endothelial dysfunction. TREND Investigators: Trial on reversing endothelial dysfunction
34. The potential use of angiotensin-converting enzyme inhibitors in patients with hyperlipidemia